Genovis AB (publ.) (STO:GENO)
22.75
-0.65 (-2.78%)
Nov 20, 2026, 5:29 PM CET
Genovis AB (publ.) Market Cap
Genovis AB (publ.) has a market cap or net worth of 1.53 billion as of November 20, 2026. It is the 21,849th most valuable company in the world and the 279th biggest in Sweden. Its market cap has increased by 14.44% in one year.
Market Cap
1.53B
Enterprise Value
1.44B
Revenue
145.23M
Global Rank
Country Rank
#279 Sweden
PE Ratio
91.03
ChartMarket Cap Chart
Since April 18, 2008, Genovis AB (publ.)'s market cap has increased from 7.51M to 1.53B, an increase of 20,325.52%. That is a compound annual growth rate of 33.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 1.53B | 9.32% |
| Dec 30, 2025 | 1.40B | -13.18% |
| Dec 30, 2024 | 1.62B | -52.50% |
| Dec 29, 2023 | 3.40B | 13.17% |
| Dec 30, 2022 | 3.01B | -37.05% |
| Dec 30, 2021 | 4.78B | 131.75% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hansa Biopharma AB | 4.59B |
| Vicore Pharma Holding AB | 2.77B |
| Saniona AB | 1.55B |
| Flerie AB | 1.08B |
| Infant Bacterial Therapeutics AB | 934.92M |
| AlzeCure Pharma AB | 783.26M |
| SynAct Pharma AB | 727.98M |
| Medivir AB | 651.64M |